-
1
-
-
77955981900
-
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction
-
COI: 1:CAS:528:DC%2BC3cXhtVeksbrJ, PID: 20679547
-
Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z et al (2010) Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122:717–728
-
(2010)
Circulation
, vol.122
, pp. 717-728
-
-
Zhong, J.1
Basu, R.2
Guo, D.3
Chow, F.L.4
Byrns, S.5
Schuster, M.6
Loibner, H.7
Wang, X.H.8
Penninger, J.M.9
Kassiri, Z.10
-
2
-
-
84864609802
-
Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction
-
COI: 1:CAS:528:DC%2BC38XhtVOjtb3K, PID: 22705769
-
Mori J, Basu R, McLean BA, Das SK, Zhang L, Patel VB, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY (2012) Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Circ Heart Fail 5:493–503
-
(2012)
Circ Heart Fail
, vol.5
, pp. 493-503
-
-
Mori, J.1
Basu, R.2
McLean, B.A.3
Das, S.K.4
Zhang, L.5
Patel, V.B.6
Wagg, C.S.7
Kassiri, Z.8
Lopaschuk, G.D.9
Oudit, G.Y.10
-
3
-
-
0034721906
-
A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
-
COI: 1:CAS:528:DC%2BD3cXnvVOqtbw%3D, PID: 10924499
-
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238–33243
-
(2000)
J Biol Chem
, vol.275
, pp. 33238-33243
-
-
Tipnis, S.R.1
Hooper, N.M.2
Hyde, R.3
Karran, E.4
Christie, G.5
Turner, A.J.6
-
4
-
-
0038053724
-
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9
-
COI: 1:CAS:528:DC%2BD3MXhslOisr8%3D, PID: 10969042
-
Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R et al (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res 87:E1–E9
-
(2000)
Circ Res
, vol.87
, pp. E1-E9
-
-
Donoghue, M.1
Hsieh, F.2
Baronas, E.3
Godbout, K.4
Gosselin, M.5
Stagliano, N.6
Donovan, M.7
Woolf, B.8
Robison, K.9
Jeyaseelan, R.10
-
5
-
-
84902291577
-
Angiotensin-(1–7)
-
COI: 1:CAS:528:DC%2BC2cXpt1KrtL0%3D, PID: 24664288
-
Santos RA (2014) Angiotensin-(1–7). Hypertension 63:1138–1147
-
(2014)
Hypertension
, vol.63
, pp. 1138-1147
-
-
Santos, R.A.1
-
6
-
-
84872227553
-
Angiotensin-(1–7): beyond the cardio-renal actions
-
COI: 1:CAS:528:DC%2BC38XhvVGrurnO
-
Passos-Silva DG, Verano-Braga T, Santos RA (2013) Angiotensin-(1–7): beyond the cardio-renal actions. Clin Sci (Lond) 124:443–456
-
(2013)
Clin Sci (Lond)
, vol.124
, pp. 443-456
-
-
Passos-Silva, D.G.1
Verano-Braga, T.2
Santos, R.A.3
-
7
-
-
84861528870
-
Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1–7 in experimental heart failure in angiotensin-converting enzyme 2-null mice
-
COI: 1:CAS:528:DC%2BC38XntVSgtro%3D, PID: 22508831
-
Patel VB, Bodiga S, Fan D, Das SK, Wang Z, Wang W, Basu R, Zhong J, Kassiri Z, Oudit GY (2012) Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1–7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Hypertension 59:1195–1203
-
(2012)
Hypertension
, vol.59
, pp. 1195-1203
-
-
Patel, V.B.1
Bodiga, S.2
Fan, D.3
Das, S.K.4
Wang, Z.5
Wang, W.6
Basu, R.7
Zhong, J.8
Kassiri, Z.9
Oudit, G.Y.10
-
8
-
-
58149352445
-
Angiotensin(1–7) blunts hypertensive cardiac remodeling by a direct effect on the heart
-
COI: 1:CAS:528:DC%2BD1cXhtlKrt7fO, PID: 18845809
-
Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL (2008) Angiotensin(1–7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103:1319–1326
-
(2008)
Circ Res
, vol.103
, pp. 1319-1326
-
-
Mercure, C.1
Yogi, A.2
Callera, G.E.3
Aranha, A.B.4
Bader, M.5
Ferreira, A.J.6
Santos, R.A.7
Walther, T.8
Touyz, R.M.9
Reudelhuber, T.L.10
-
9
-
-
84862648459
-
Role of ACE2 in diastolic and systolic heart failure
-
COI: 1:CAS:528:DC%2BC38XosFCkur4%3D, PID: 21638102
-
Wang W, Bodiga S, Das SK, Lo J, Patel V, Oudit GY (2012) Role of ACE2 in diastolic and systolic heart failure. Heart Fail Rev 17:683–691
-
(2012)
Heart Fail Rev
, vol.17
, pp. 683-691
-
-
Wang, W.1
Bodiga, S.2
Das, S.K.3
Lo, J.4
Patel, V.5
Oudit, G.Y.6
-
10
-
-
0033542476
-
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
-
COI: 1:CAS:528:DyaK1MXjvFegu7s%3D, PID: 10376603
-
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605
-
(1999)
Nature
, vol.399
, pp. 601-605
-
-
Dimmeler, S.1
Fleming, I.2
Fisslthaler, B.3
Hermann, C.4
Busse, R.5
Zeiher, A.M.6
-
11
-
-
84894049935
-
Modulation of the action of insulin by angiotensin-(1–7)
-
COI: 1:CAS:528:DC%2BC2cXhtVOit7Y%3D
-
Dominici FP, Burghi V, Munoz MC, Giani JF (2014) Modulation of the action of insulin by angiotensin-(1–7). Clin Sci (Lond) 126:613–630
-
(2014)
Clin Sci (Lond)
, vol.126
, pp. 613-630
-
-
Dominici, F.P.1
Burghi, V.2
Munoz, M.C.3
Giani, J.F.4
-
12
-
-
33847018997
-
Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways
-
COI: 1:CAS:528:DC%2BD28XhtlSrs7jF, PID: 17116756
-
Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM (2007) Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49:185–192
-
(2007)
Hypertension
, vol.49
, pp. 185-192
-
-
Sampaio, W.O.1
Souza dos Santos, R.A.2
Faria-Silva, R.3
da Mata Machado, L.T.4
Schiffrin, E.L.5
Touyz, R.M.6
-
13
-
-
73849095442
-
Angiotensin-(1–7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3′,5′-cyclic monophosphate-dependent pathway
-
COI: 1:CAS:528:DC%2BD1MXhsFaqtL7K, PID: 19996065
-
Gomes ER, Lara AA, Almeida PW, Guimaraes D, Resende RR, Campagnole-Santos MJ, Bader M, Santos RA, Guatimosim S (2010) Angiotensin-(1–7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3′,5′-cyclic monophosphate-dependent pathway. Hypertension 55:153–160
-
(2010)
Hypertension
, vol.55
, pp. 153-160
-
-
Gomes, E.R.1
Lara, A.A.2
Almeida, P.W.3
Guimaraes, D.4
Resende, R.R.5
Campagnole-Santos, M.J.6
Bader, M.7
Santos, R.A.8
Guatimosim, S.9
-
14
-
-
0028061656
-
Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors
-
COI: 1:CAS:528:DyaK2MXitFCqs7w%3D, PID: 7850477
-
Santos RA, Campagnole-Santos MJ, Baracho NC, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues AR, Gropen Junior C et al (1994) Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors. Brain Res Bull 35:293–298
-
(1994)
Brain Res Bull
, vol.35
, pp. 293-298
-
-
Santos, R.A.1
Campagnole-Santos, M.J.2
Baracho, N.C.3
Fontes, M.A.4
Silva, L.C.5
Neves, L.A.6
Oliveira, D.R.7
Caligiorne, S.M.8
Rodrigues, A.R.9
Gropen Junior, C.10
-
15
-
-
0037478671
-
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
-
COI: 1:CAS:528:DC%2BD3sXlsFGnsbc%3D, PID: 12829792
-
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M et al (2003) Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100:8258–8263
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 8258-8263
-
-
Santos, R.A.1
Simoes e Silva, A.C.2
Maric, C.3
Silva, D.M.4
Machado, R.P.5
de Buhr, I.6
Heringer-Walther, S.7
Pinheiro, S.V.8
Lopes, M.T.9
Bader, M.10
-
16
-
-
79958820082
-
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit
-
COI: 1:CAS:528:DC%2BC3MXnsFWmt7k%3D, PID: 21285291
-
Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM et al (2011) Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res 91:151–161
-
(2011)
Cardiovasc Res
, vol.91
, pp. 151-161
-
-
Bodiga, S.1
Zhong, J.C.2
Wang, W.3
Basu, R.4
Lo, J.5
Liu, G.C.6
Guo, D.7
Holland, S.M.8
Scholey, J.W.9
Penninger, J.M.10
-
17
-
-
84861099242
-
Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis
-
COI: 1:CAS:528:DC%2BC38XmvVKmtro%3D, PID: 22474255
-
Patel VB, Bodiga S, Basu R, Das SK, Wang W, Wang Z, Lo J, Grant MB, Zhong J, Kassiri Z et al (2012) Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis. Circ Res 110:1322–1335
-
(2012)
Circ Res
, vol.110
, pp. 1322-1335
-
-
Patel, V.B.1
Bodiga, S.2
Basu, R.3
Das, S.K.4
Wang, W.5
Wang, Z.6
Lo, J.7
Grant, M.B.8
Zhong, J.9
Kassiri, Z.10
-
18
-
-
84903398785
-
Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology
-
PID: 24923671
-
Putko BN, Wang Z, Lo J, Anderson T, Becher H, Dyck JR, Kassiri Z, Oudit GY, Alberta HI (2014) Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology. PLoS One 9, e99495. doi:10.1371/journal.pone.0099495
-
(2014)
PLoS One
, vol.9
-
-
Putko, B.N.1
Wang, Z.2
Lo, J.3
Anderson, T.4
Becher, H.5
Dyck, J.R.6
Kassiri, Z.7
Oudit, G.Y.8
Alberta, H.I.9
-
19
-
-
84902532919
-
Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling
-
COI: 1:CAS:528:DC%2BC2cXpsFKnsL0%3D, PID: 24799609
-
Patel VB, Zhong JC, Fan D, Basu R, Morton JS, Parajuli N, McMurtry MS, Davidge ST, Kassiri Z, Oudit GY (2014) Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling. Hypertension 64:157–164
-
(2014)
Hypertension
, vol.64
, pp. 157-164
-
-
Patel, V.B.1
Zhong, J.C.2
Fan, D.3
Basu, R.4
Morton, J.S.5
Parajuli, N.6
McMurtry, M.S.7
Davidge, S.T.8
Kassiri, Z.9
Oudit, G.Y.10
-
20
-
-
70350457666
-
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction
-
COI: 1:CAS:528:DC%2BD1MXhtV2qs73P, PID: 19808375
-
Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY (2009) Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail 2:446–455
-
(2009)
Circ Heart Fail
, vol.2
, pp. 446-455
-
-
Kassiri, Z.1
Zhong, J.2
Guo, D.3
Basu, R.4
Wang, X.5
Liu, P.P.6
Scholey, J.W.7
Penninger, J.M.8
Oudit, G.Y.9
-
21
-
-
0025770664
-
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
-
COI: 1:STN:280:DyaK3M3kvFChtg%3D%3D, PID: 1828192
-
Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849–1865
-
(1991)
Circulation
, vol.83
, pp. 1849-1865
-
-
Weber, K.T.1
Brilla, C.G.2
-
22
-
-
28144432331
-
Angiotensin-(1–7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects
-
COI: 1:CAS:528:DC%2BD28XlslGnsA%3D%3D, PID: 16024575
-
Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX, Greenberg BH (2005) Angiotensin-(1–7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289:H2356–H2363
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
, pp. H2356-H2363
-
-
Iwata, M.1
Cowling, R.T.2
Gurantz, D.3
Moore, C.4
Zhang, S.5
Yuan, J.X.6
Greenberg, B.H.7
-
23
-
-
79551485466
-
Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2
-
COI: 1:CAS:528:DC%2BC3MXnvVWlsg%3D%3D, PID: 21189404
-
Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY (2011) Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 57:314–322
-
(2011)
Hypertension
, vol.57
, pp. 314-322
-
-
Zhong, J.1
Guo, D.2
Chen, C.B.3
Wang, W.4
Schuster, M.5
Loibner, H.6
Penninger, J.M.7
Scholey, J.W.8
Kassiri, Z.9
Oudit, G.Y.10
-
24
-
-
84857231867
-
Angiotensin signalling in pulmonary fibrosis
-
COI: 1:CAS:528:DC%2BC38XjtFSitbo%3D, PID: 22155301
-
Uhal BD, Li X, Piasecki CC, Molina-Molina M (2012) Angiotensin signalling in pulmonary fibrosis. Int J Biochem Cell Biol 44:465–468
-
(2012)
Int J Biochem Cell Biol
, vol.44
, pp. 465-468
-
-
Uhal, B.D.1
Li, X.2
Piasecki, C.C.3
Molina-Molina, M.4
-
25
-
-
0028365310
-
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
-
COI: 1:CAS:528:DyaK2cXksFSlu7s%3D, PID: 8187280
-
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148
-
(1994)
Circ Res
, vol.74
, pp. 1141-1148
-
-
Griendling, K.K.1
Minieri, C.A.2
Ollerenshaw, J.D.3
Alexander, R.W.4
-
26
-
-
33846362954
-
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
-
COI: 1:CAS:528:DC%2BD2sXisFCrtLc%3D, PID: 16870827
-
Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82–C97
-
(2007)
Am J Physiol Cell Physiol
, vol.292
, pp. C82-C97
-
-
Mehta, P.K.1
Griendling, K.K.2
-
27
-
-
36448975192
-
Angiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cells
-
COI: 1:CAS:528:DC%2BD2sXht1yku7nF, PID: 17984366
-
Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM (2007) Angiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50:1093–1098
-
(2007)
Hypertension
, vol.50
, pp. 1093-1098
-
-
Sampaio, W.O.1
Henrique de Castro, C.2
Santos, R.A.3
Schiffrin, E.L.4
Touyz, R.M.5
-
28
-
-
0038165407
-
Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases
-
COI: 1:CAS:528:DC%2BD3sXks1Kmsrc%3D, PID: 12764022
-
Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM (2003) Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92:1322–1329
-
(2003)
Circ Res
, vol.92
, pp. 1322-1329
-
-
Khan, S.A.1
Skaf, M.W.2
Harrison, R.W.3
Lee, K.4
Minhas, K.M.5
Kumar, A.6
Fradley, M.7
Shoukas, A.A.8
Berkowitz, D.E.9
Hare, J.M.10
-
29
-
-
33846418746
-
Role of oxidative stress in cardiac hypertrophy and remodeling
-
COI: 1:CAS:528:DC%2BD2sXivFKrtg%3D%3D, PID: 17190878
-
Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241–248
-
(2007)
Hypertension
, vol.49
, pp. 241-248
-
-
Takimoto, E.1
Kass, D.A.2
-
30
-
-
33748323383
-
Regulation of cardiac hypertrophy by intracellular signalling pathways
-
COI: 1:CAS:528:DC%2BD28Xot1Cqu78%3D, PID: 16936699
-
Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589–600
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 589-600
-
-
Heineke, J.1
Molkentin, J.D.2
-
31
-
-
84900031278
-
Angiotensin 1–7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation
-
COI: 1:CAS:528:DC%2BC2cXkslCrtLs%3D, PID: 24389129
-
Mori J, Patel VB, Abo Alrob O, Basu R, Altamimi T, Desaulniers J, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY (2014) Angiotensin 1–7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail 7:327–339
-
(2014)
Circ Heart Fail
, vol.7
, pp. 327-339
-
-
Mori, J.1
Patel, V.B.2
Abo Alrob, O.3
Basu, R.4
Altamimi, T.5
Desaulniers, J.6
Wagg, C.S.7
Kassiri, Z.8
Lopaschuk, G.D.9
Oudit, G.Y.10
-
32
-
-
84900557163
-
Angiotensin 1–7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity
-
COI: 1:CAS:528:DC%2BC2cXns1GrtLc%3D, PID: 24553436
-
Mori J, Patel VB, Ramprasath T, Alrob OA, DesAulniers J, Scholey JW, Lopaschuk GD, Oudit GY (2014) Angiotensin 1–7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol 306:F812–F821
-
(2014)
Am J Physiol Renal Physiol
, vol.306
, pp. F812-F821
-
-
Mori, J.1
Patel, V.B.2
Ramprasath, T.3
Alrob, O.A.4
DesAulniers, J.5
Scholey, J.W.6
Lopaschuk, G.D.7
Oudit, G.Y.8
-
33
-
-
80055049289
-
Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy
-
COI: 1:CAS:528:DC%2BC3MXps1yksrc%3D, PID: 21611889
-
Oudit GY, Penninger JM (2011) Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy. Curr Heart Fail Rep 8:176–183
-
(2011)
Curr Heart Fail Rep
, vol.8
, pp. 176-183
-
-
Oudit, G.Y.1
Penninger, J.M.2
-
34
-
-
84891420160
-
Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
-
COI: 1:CAS:528:DC%2BC3sXhvFCjsr%2FF
-
Patel VB, Parajuli N, Oudit GY (2014) Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin Sci (Lond) 126:471–482
-
(2014)
Clin Sci (Lond)
, vol.126
, pp. 471-482
-
-
Patel, V.B.1
Parajuli, N.2
Oudit, G.Y.3
-
35
-
-
84872178401
-
Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats
-
COI: 1:CAS:528:DC%2BC3sXjvVOmsL0%3D, PID: 22750422
-
Lo J, Patel VB, Wang Z, Levasseur J, Kaufman S, Penninger JM, Oudit GY (2013) Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Exp Physiol 98:109–122
-
(2013)
Exp Physiol
, vol.98
, pp. 109-122
-
-
Lo, J.1
Patel, V.B.2
Wang, Z.3
Levasseur, J.4
Kaufman, S.5
Penninger, J.M.6
Oudit, G.Y.7
-
36
-
-
73849101073
-
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension
-
COI: 1:CAS:528:DC%2BD1MXhsFaqtL7M, PID: 19948988
-
Wysocki J, Ye M, Rodriguez E, Gonzalez-Pacheco FR, Barrios C, Evora K, Schuster M, Loibner H, Brosnihan KB, Ferrario CM et al (2010) Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55:90–98
-
(2010)
Hypertension
, vol.55
, pp. 90-98
-
-
Wysocki, J.1
Ye, M.2
Rodriguez, E.3
Gonzalez-Pacheco, F.R.4
Barrios, C.5
Evora, K.6
Schuster, M.7
Loibner, H.8
Brosnihan, K.B.9
Ferrario, C.M.10
-
37
-
-
84865563408
-
Recombinant expression and characterization of human and murine ACE2: species-specific activation of the alternative renin-angiotensin-system
-
PID: 22518284
-
Poglitsch M, Domenig O, Schwager C, Stranner S, Peball B, Janzek E, Wagner B, Jungwirth H, Loibner H, Schuster M (2012) Recombinant expression and characterization of human and murine ACE2: species-specific activation of the alternative renin-angiotensin-system. Int J Hypertens 2012:428950
-
(2012)
Int J Hypertens
, vol.2012
, pp. 428950
-
-
Poglitsch, M.1
Domenig, O.2
Schwager, C.3
Stranner, S.4
Peball, B.5
Janzek, E.6
Wagner, B.7
Jungwirth, H.8
Loibner, H.9
Schuster, M.10
-
38
-
-
84883202259
-
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects
-
COI: 1:CAS:528:DC%2BC3sXhvVWmtLvF, PID: 23681967
-
Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, Penninger J, Krahenbuhl S (2013) Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet 52:783–792
-
(2013)
Clin Pharmacokinet
, vol.52
, pp. 783-792
-
-
Haschke, M.1
Schuster, M.2
Poglitsch, M.3
Loibner, H.4
Salzberg, M.5
Bruggisser, M.6
Penninger, J.7
Krahenbuhl, S.8
-
39
-
-
77953177090
-
Simultaneous administration of Ang(1–7) or A-779 does not affect the chronic hypertensive effects of angiotensin II in normal rats
-
COI: 1:CAS:528:DC%2BC3cXhtVykt7bK, PID: 20357049
-
Collister JP, Nahey DB (2010) Simultaneous administration of Ang(1–7) or A-779 does not affect the chronic hypertensive effects of angiotensin II in normal rats. J Renin Angiotensin Aldosterone Syst 11:99–102
-
(2010)
J Renin Angiotensin Aldosterone Syst
, vol.11
, pp. 99-102
-
-
Collister, J.P.1
Nahey, D.B.2
-
40
-
-
84906790448
-
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease
-
COI: 1:CAS:528:DC%2BC2cXms1Cgurc%3D
-
Wang W, Patel VB, Parajuli N, Fan D, Basu R, Wang Z, Ramprasath T, Kassiri Z, Penninger JM, Oudit GY (2014) Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease. J Mol Med (Berl) 92:847–858
-
(2014)
J Mol Med (Berl)
, vol.92
, pp. 847-858
-
-
Wang, W.1
Patel, V.B.2
Parajuli, N.3
Fan, D.4
Basu, R.5
Wang, Z.6
Ramprasath, T.7
Kassiri, Z.8
Penninger, J.M.9
Oudit, G.Y.10
-
41
-
-
77449160523
-
Human recombinant ACE2 reduces the progression of diabetic nephropathy
-
COI: 1:CAS:528:DC%2BC3cXhvVyqsro%3D, PID: 19934006
-
Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, Zhou J, Loibner H, Janzek E, Schuster M, Penninger JM et al (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59:529–538
-
(2010)
Diabetes
, vol.59
, pp. 529-538
-
-
Oudit, G.Y.1
Liu, G.C.2
Zhong, J.3
Basu, R.4
Chow, F.L.5
Zhou, J.6
Loibner, H.7
Janzek, E.8
Schuster, M.9
Penninger, J.M.10
-
42
-
-
84898472204
-
Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats
-
COI: 1:CAS:528:DC%2BC3sXhslSlsbzK
-
Santos SH, Giani JF, Burghi V, Miquet JG, Qadri F, Braga JF, Todiras M, Kotnik K, Alenina N, Dominici FP et al (2014) Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats. J Mol Med (Berl) 92:255–265
-
(2014)
J Mol Med (Berl)
, vol.92
, pp. 255-265
-
-
Santos, S.H.1
Giani, J.F.2
Burghi, V.3
Miquet, J.G.4
Qadri, F.5
Braga, J.F.6
Todiras, M.7
Kotnik, K.8
Alenina, N.9
Dominici, F.P.10
-
43
-
-
47649122637
-
Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy
-
COI: 1:CAS:528:DC%2BD1cXlvVCntrg%3D, PID: 18474817
-
Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK et al (2008) Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117:2626–2636
-
(2008)
Circulation
, vol.117
, pp. 2626-2636
-
-
Moens, A.L.1
Takimoto, E.2
Tocchetti, C.G.3
Chakir, K.4
Bedja, D.5
Cormaci, G.6
Ketner, E.A.7
Majmudar, M.8
Gabrielson, K.9
Halushka, M.K.10
-
44
-
-
84903550813
-
Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure
-
COI: 1:CAS:528:DC%2BC2cXnvFemu7Y%3D
-
Parajuli N, Patel VB, Wang W, Basu R, Oudit GY (2014) Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure. Clin Sci (Lond) 127:331–340
-
(2014)
Clin Sci (Lond)
, vol.127
, pp. 331-340
-
-
Parajuli, N.1
Patel, V.B.2
Wang, W.3
Basu, R.4
Oudit, G.Y.5
-
45
-
-
52049095952
-
Molecular mechanisms involved in the angiotensin-(1–7)/Mas signaling pathway in cardiomyocytes
-
COI: 1:CAS:528:DC%2BD1cXpvFKgs7g%3D, PID: 18695148
-
Dias-Peixoto MF, Santos RA, Gomes ER, Alves MN, Almeida PW, Greco L, Rosa M, Fauler B, Bader M, Alenina N et al (2008) Molecular mechanisms involved in the angiotensin-(1–7)/Mas signaling pathway in cardiomyocytes. Hypertension 52:542–548
-
(2008)
Hypertension
, vol.52
, pp. 542-548
-
-
Dias-Peixoto, M.F.1
Santos, R.A.2
Gomes, E.R.3
Alves, M.N.4
Almeida, P.W.5
Greco, L.6
Rosa, M.7
Fauler, B.8
Bader, M.9
Alenina, N.10
-
46
-
-
24344509196
-
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1–7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice
-
COI: 1:CAS:528:DC%2BD2MXovVKrt7w%3D, PID: 16116331
-
Lemos VS, Silva DM, Walther T, Alenina N, Bader M, Santos RA (2005) The endothelium-dependent vasodilator effect of the nonpeptide Ang(1–7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice. J Cardiovasc Pharmacol 46:274–279
-
(2005)
J Cardiovasc Pharmacol
, vol.46
, pp. 274-279
-
-
Lemos, V.S.1
Silva, D.M.2
Walther, T.3
Alenina, N.4
Bader, M.5
Santos, R.A.6
-
47
-
-
77749254756
-
Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner
-
COI: 1:CAS:528:DC%2BC3cXjsFGgsrw%3D, PID: 20007453
-
Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, Davidge ST, Oudit GY, Kassiri Z (2010) Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol Cell Physiol 298:C679–C692
-
(2010)
Am J Physiol Cell Physiol
, vol.298
, pp. C679-C692
-
-
Awad, A.E.1
Kandalam, V.2
Chakrabarti, S.3
Wang, X.4
Penninger, J.M.5
Davidge, S.T.6
Oudit, G.Y.7
Kassiri, Z.8
-
48
-
-
78549277139
-
Loss of PI3Kgamma enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress
-
COI: 1:CAS:528:DC%2BC3cXhsVWht7%2FI, PID: 20847309
-
Guo D, Kassiri Z, Basu R, Chow FL, Kandalam V, Damilano F, Liang W, Izumo S, Hirsch E, Penninger JM et al (2010) Loss of PI3Kgamma enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress. Circ Res 107:1275–1289
-
(2010)
Circ Res
, vol.107
, pp. 1275-1289
-
-
Guo, D.1
Kassiri, Z.2
Basu, R.3
Chow, F.L.4
Kandalam, V.5
Damilano, F.6
Liang, W.7
Izumo, S.8
Hirsch, E.9
Penninger, J.M.10
-
49
-
-
33846987938
-
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)
-
COI: 1:CAS:528:DC%2BD2sXjt1Gns7s%3D, PID: 17098828
-
Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7). Am J Physiol Heart Circ Physiol 292:H736–H742
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, pp. H736-H742
-
-
Grobe, J.L.1
Mecca, A.P.2
Lingis, M.3
Shenoy, V.4
Bolton, T.A.5
Machado, J.M.6
Speth, R.C.7
Raizada, M.K.8
Katovich, M.J.9
-
50
-
-
80051949470
-
Lentivirus-mediated overexpression of angiotensin-(1–7) attenuated ischaemia-induced cardiac pathophysiology
-
COI: 1:CAS:528:DC%2BC3MXhtlOmsLjF, PID: 21685447
-
Qi Y, Shenoy V, Wong F, Li H, Afzal A, Mocco J, Sumners C, Raizada MK, Katovich MJ (2011) Lentivirus-mediated overexpression of angiotensin-(1–7) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol 96:863–874
-
(2011)
Exp Physiol
, vol.96
, pp. 863-874
-
-
Qi, Y.1
Shenoy, V.2
Wong, F.3
Li, H.4
Afzal, A.5
Mocco, J.6
Sumners, C.7
Raizada, M.K.8
Katovich, M.J.9
-
51
-
-
84875442204
-
Angiotensin 1–7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model
-
COI: 1:CAS:528:DC%2BC3sXpvFCktbc%3D, PID: 23250359
-
Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T et al (2013) Angiotensin 1–7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 62:1121–1130
-
(2013)
Diabetes
, vol.62
, pp. 1121-1130
-
-
Marcus, Y.1
Shefer, G.2
Sasson, K.3
Kohen, F.4
Limor, R.5
Pappo, O.6
Nevo, N.7
Biton, I.8
Bach, M.9
Berkutzki, T.10
|